Title : Distinguishing among incretin-based therapies. Pathophysiology of type 2 diabetes mellitus: potential role of incretin-based therapies.

Pub. Date : 2010 Sep

PMID : 20824239






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In addition to improving insulin resistance and pancreatic beta-cell dysfunction, the GLP-1 agonists and DPP-4 inhibitors improve the impaired incretin response, as well as increase insulin secretion and reduce glucagon secretion, both in a glucose-dependent manner. Glucagon dipeptidyl peptidase 4 Homo sapiens